| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091052730 |
| P356 | DOI | 10.1007/S11886-017-0893-3 |
| P698 | PubMed publication ID | 28779285 |
| P50 | author | Andrea Natale | Q4755205 |
| Jorge Romero | Q42843720 | ||
| P2093 | author name string | Luigi Di Biase | |
| David F Briceño | |||
| Michael Grushko | |||
| P2860 | cites work | Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. | Q55638651 |
| Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q57736293 | ||
| Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia | Q58814810 | ||
| Electroanatomic Substrate and Outcome of Catheter Ablative Therapy for Ventricular Tachycardia in Setting of Right Ventricular Cardiomyopathy | Q58815168 | ||
| Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q59248773 | ||
| Arrhythmogenic right ventricular dysplasia: a generalized cardiomyopathy? | Q64764605 | ||
| Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia | Q68182850 | ||
| Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia | Q69375234 | ||
| Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia | Q77313178 | ||
| Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies | Q83058651 | ||
| Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique | Q83150726 | ||
| Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia | Q84521517 | ||
| Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention | Q84974205 | ||
| Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy | Q86644555 | ||
| Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy | Q87342748 | ||
| Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement | Q26799143 | ||
| Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q33150735 | ||
| ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui | Q33156283 | ||
| Nonischemic sustained ventricular tachycardia: clinical outcome in 12 patients with arrhythmogenic right ventricular dysplasia | Q33167383 | ||
| Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. | Q33175413 | ||
| Dysplastic conditions of the right ventricular myocardium: Uhl's anomaly vs arrhythmogenic right ventricular dysplasia | Q33612249 | ||
| Right ventricular dysplasia: a report of 24 adult cases | Q34714742 | ||
| Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia | Q34796656 | ||
| The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5) | Q35097764 | ||
| Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review | Q36887235 | ||
| Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry | Q37357225 | ||
| Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy | Q40603082 | ||
| Significance of intraventricular conduction disorders observed in arrhythmogenic right ventricular dysplasia | Q41573000 | ||
| Role of Bilateral Sympathectomy in the Treatment of Refractory Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q41625271 | ||
| Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy | Q43530183 | ||
| An electrocardiographic scoring system for distinguishing right ventricular outflow tract arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia | Q44019017 | ||
| Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy | Q44810983 | ||
| Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q51023298 | ||
| ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo | Q51137889 | ||
| Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making? | Q51547154 | ||
| Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q51625256 | ||
| Electrode catheter ablation of resistant ventricular tachycardia in arrhythmogenic right ventricular dysplasia: experience of 13 patients with a mean follow-up of 45 months. | Q52244977 | ||
| Arrhythmogenic Right Ventricular Cardiomyopathy. | Q52932634 | ||
| P433 | issue | 9 | |
| P921 | main subject | arrhythmogenic right ventricular cardiomyopathy | Q2555727 |
| P304 | page(s) | 82 | |
| P577 | publication date | 2017-09-01 | |
| P1433 | published in | Current cardiology reports | Q26842345 |
| P1476 | title | Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) | |
| P478 | volume | 19 |
| Q55037788 | Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice. |
| Q89885433 | My approach to ventricular tachycardia ablation in patient with arrhythmogenic right ventricular cardiomyopathy/dysplasia |
| Q92867877 | Right ventricular free-wall scar: an exceptional source of post-infarction ventricular tachycardia. A case report |
Search more.